Investor Relations

Analyst Reports

Year  : 
May
29
Kenanga Research - Won RM281m Contract Insulin
May
29
MBSB Research - RM282m MOH Contract to Contribute in FY26
May
21
BIMB Securities Research - Vision ONE30 Flight Ready for Take-Off
May
19
BIMB Securities Research - Manufacturing-Led Re-Rating Is Underway
May
19
Kenanga Research - 1QFY26 In Line, Rich Valuation
May
19
MBSB Research - Higher Drug Demand Supported Manufacturing in 1QFY26
Mar
17
BIMB Securities Research - Manufacturing-Led Transformation Under Vision ONE30
Feb
26
MBSB Research - Strong Support Expected in FY26 Onwards
Feb
24
Kenanga Research - FY25 Inline, Rich Valuation
Feb
24
MBSB Research - Higher Drug Demand to Support